Ivan B Filippenkov
Overview
Explore the profile of Ivan B Filippenkov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Filippenkov I, Shpetko Y, Stavchansky V, Denisova A, Yuzhakov V, Fomina N, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076966
Ischemic stroke is a multifactorial disease that leads to brain tissue damage and severe neurological deficit. Transient middle cerebral artery occlusion (tMCAO) models are actively used for the molecular, genetic...
2.
Filippenkov I, Shpetko Y, Stavchansky V, Denisova A, Gubsky L, Andreeva L, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767736
Ischemic stroke results from a disruption of cerebral blood flow. Adrenocorticotropic hormone (ACTH) serves as the basis for the creation of synthetic peptides as neuroprotective agents for stroke therapy. Previously,...
3.
Filippenkov I, Glazova N, Sebentsova E, Stavchansky V, Andreeva L, Myasoedov N, et al.
Biochemistry (Mosc)
. 2024 Oct;
89(9):1643-1656.
PMID: 39418522
Synthetic peptides have a wide range of clinical effects. Of particular interest are peptides based on adrenocorticotropic hormone (ACTH) both as already used and as potential drugs for preventing consequences...
4.
Stavchansky V, Yuzhakov V, Sevankaeva L, Fomina N, Koretskaya A, Denisova A, et al.
Curr Issues Mol Biol
. 2024 Mar;
46(3):2071-2092.
PMID: 38534749
Stroke remains the second leading cause of death worldwide. The development of new therapeutic agents focused on restoring vascular function and neuroprotection of viable tissues is required. In this study...
5.
Filippenkov I, Khrunin A, Mozgovoy I, Dergunova L, Limborska S
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893101
Complex diseases that affect the functioning of the central nervous system pose a major problem for modern society. Among these, ischemic stroke (IS) holds a special place as one of...
6.
Dergunova L, Vinogradina M, Filippenkov I, Limborska S, Dergunov A
Curr Issues Mol Biol
. 2023 Aug;
45(8):6682-6700.
PMID: 37623241
Over the past decade, numerous studies have shown that circular RNAs (circRNAs) play a significant role in coronary artery atherogenesis and other cardiovascular diseases. They belong to the class of...
7.
Isoflurane Anesthesia's Impact on Gene Expression Patterns of Rat Brains in an Ischemic Stroke Model
Shpetko Y, Filippenkov I, Denisova A, Stavchansky V, Gubsky L, Limborska S, et al.
Genes (Basel)
. 2023 Jul;
14(7).
PMID: 37510352
Background: Ischemic stroke (IS) is one of the most severe brain diseases. Animal models with anesthesia are actively used to study stroke genomics and pathogenesis. However, the anesthesia-related gene expression...
8.
Filippenkov I, Remizova J, Stavchansky V, Denisova A, Gubsky L, Myasoedov N, et al.
Genes (Basel)
. 2023 Jul;
14(7).
PMID: 37510287
Ischemic stroke is an acute local decrease in cerebral blood flow due to a thrombus or embolus. Of particular importance is the study of the genetic systems that determine the...
9.
Dergunova L, Filippenkov I, Limborska S, Myasoedov N
Genes (Basel)
. 2023 May;
14(5).
PMID: 37239313
Ischemic stroke continues to be one of the leading causes of death and disability in the adult population worldwide. The currently used pharmacological methods for the treatment of ischemic stroke...
10.
Limborska S, Filippenkov I
Genes (Basel)
. 2023 Feb;
14(2).
PMID: 36833441
Stroke is one of the greatest medical threats to human health and quality of life in modern society [...].